mRNA (BNT162b2) and Inactivated (CoronaVac) COVID-19 Vaccination and Risk of Adverse Events and Acute Diabetic Complications in Patients with Type 2 Diabetes Mellitus: A Population-Based Study

INTRODUCTION: In Hong Kong, CoronaVac and BNT162b2 have been approved for emergency use owing to the coronavirus disease 2019 (COVID-19) pandemic. Reactions towards the vaccine and the risk of post-vaccination adverse events may be different between recipients with and without type 2 diabetes mellit...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Eric Yuk Fai, Chui, Celine Sze Ling, Mok, Anna Hoi Ying, Xu, Wanchun, Yan, Vincent Ka Chun, Lai, Francisco Tsz Tsun, Li, Xue, Wong, Carlos King Ho, Chan, Esther Wai Yin, Lui, David Tak Wai, Tan, Kathryn Choon Beng, Hung, Ivan Fan Ngai, Lam, Cindy Lo Kuen, Leung, Gabriel Matthew, Wong, Ian Chi Kei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527074/
https://www.ncbi.nlm.nih.gov/pubmed/36184720
http://dx.doi.org/10.1007/s40264-022-01228-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527074/
https://www.ncbi.nlm.nih.gov/pubmed/36184720
http://dx.doi.org/10.1007/s40264-022-01228-6

Ejemplares similares